STOCKHOLM, Feb. 6, 2024 /PRNewswire/ — BioArctic AB’s (publ) (STO: BIOA-B) partner Eisai today issued their quarterly report containing Leqembi sales for the fourth quarter 2023 (third quarter of Eisai’s fiscal year, ending March 2024). In total, sales of JPY 1.1 billion were recorded in…